Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the...

Full description

Saved in:
Bibliographic Details
Main Authors Lu, Susan, Korz, Walter, Wong, Donald, Baeyens, Jose Manuel, Hernandez, Jose Miguel Vela, Buschmann, Helmut Heinrich
Format Patent
LanguageEnglish
Published 11.12.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.
AbstractList The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.
Author Hernandez, Jose Miguel Vela
Lu, Susan
Buschmann, Helmut Heinrich
Baeyens, Jose Manuel
Wong, Donald
Korz, Walter
Author_xml – fullname: Lu, Susan
– fullname: Korz, Walter
– fullname: Wong, Donald
– fullname: Baeyens, Jose Manuel
– fullname: Hernandez, Jose Miguel Vela
– fullname: Buschmann, Helmut Heinrich
BookMark eNqNzDsOwjAQRdEUUPDbw7AAJBJAghYEoofU0eC8EItkxtgOErvnIxZAdZujO0x6ooJB4vIA0oqClrZrydQsgoYujZobfKBKPcUaFD04tpD4wYLOq-NYW0OOrVCJBxp1Vq7EgZiMSsC9g5jv3NRo9X3x7J7jpF9xEzD5dZRMD_vz7jiD0wLBsYEgFvkpnafLzXqVbbPFP-YFuE9FWg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10149852B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10149852B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:39:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10149852B23
Notes Application Number: US201615268378
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181211&DB=EPODOC&CC=US&NR=10149852B2
ParticipantIDs epo_espacenet_US10149852B2
PublicationCentury 2000
PublicationDate 20181211
PublicationDateYYYYMMDD 2018-12-11
PublicationDate_xml – month: 12
  year: 2018
  text: 20181211
  day: 11
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies Wex Medical Limited
WEX PHARMACEUTICALS INC
RelatedCompanies_xml – name: Wex Medical Limited
– name: WEX PHARMACEUTICALS INC
Score 3.1851583
Snippet The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181211&DB=EPODOC&locale=&CC=US&NR=10149852B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVdH6YATpLZi0aR6HIDRpKUIf2EZ6K7t5QKtNgkkR_72zS9p40VvYLEsyyzczyc73DcAj0w3R991SAo2rit4ObYUZKiNcmSG3IjXmUm1_NDaGvv6y6C5qsN5xYaRO6JcURyREBYT3QvrrrPqJ5cnayvyJr2gofR7MHa9Vfh2LcEXY9XpOfzrxJm7LdR1_1hq_OqIlrW112z1y1wcijRY6-_23nmClZL9DyuAUDqe0WlKcQS1KGnDs7jqvNeBoVB5402WJvfwcMj-PMI0xT8PVdoOCsZtEH8gpGr1TDoeUfSJlc7gvHReTpVyl7DocYMZWCVYkKWQ5Mgyqamoxn7ZwU3Kyvi_gYdCfu0OFHn25t9PSn1Vv2bmEepIm0RWgEWt6zE3VbIeqrpsmJ_9nd8T5ZiewGYuvofn3Os3_bt7AibC5qO7QtFuoF5_b6I5idMHvpXF_AFd9mBk
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSP4WhPDrbGF0tJDY0ILQaWFCDXcyG4fCSptY0uM_97ZTaFe9NZsN5vtbL55dOebAbijqsb7vvckX2GypLYDQ6KaTBFXesB6oRwxUW3fcbWRpz4tuosKvG25MKJO6JcojoiI8hHvudDXafkTyxa5ldk9W-FQ8jCcm3ariI65uULs2n1zMJ3YE6tlWaY3a7kvJm9Ja_S67T6q6z0dQ0IRKr32OSsl_W1ShkewP8XV4vwYKmFch5q17bxWhwOnuPDGxwJ72QmkXhaSJCJZEqw2a8IZu3H4QRhao3f04Qh6nwS9ObJLHeeTRblK0XXYJyldxaQkSRGaEUr8Mpuaz8cjXBecrO9TuB0O5tZIwq0vd3JaerPyKztnUI2TODwHokWKGjFd1tuBrKq6zlD_GR1-v9nxDUqjBjT_Xqf538sbqI3mzng5fnSfL-CQy59neijKJVTzz014hfY6Z9dC0D-Z7psD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+sodium+channel+blockers+for+the+treatment+of+neuropathic+pain+developing+as+a+consequence+of+chemotherapy&rft.inventor=Lu%2C+Susan&rft.inventor=Korz%2C+Walter&rft.inventor=Wong%2C+Donald&rft.inventor=Baeyens%2C+Jose+Manuel&rft.inventor=Hernandez%2C+Jose+Miguel+Vela&rft.inventor=Buschmann%2C+Helmut+Heinrich&rft.date=2018-12-11&rft.externalDBID=B2&rft.externalDocID=US10149852B2